Log in

NASDAQ:SBBPStrongbridge Biopharma News Headlines

$1.74
-0.19 (-9.84 %)
(As of 04/6/2020 07:43 AM ET)
Add
Compare
Today's Range
$1.73
Now: $1.74
$1.97
50-Day Range
$1.57
MA: $2.49
$3.51
52-Week Range
$1.43
Now: $1.74
$5.03
Volume329,516 shs
Average Volume316,372 shs
Market Capitalization$94.40 million
P/E RatioN/A
Dividend YieldN/A
Beta1.03

Headlines

Strongbridge Biopharma (NASDAQ SBBP) News Headlines

Source:
DateHeadline
Strongbridge Biopharma plc (NASDAQ:SBBP) Expected to Announce Quarterly Sales of $5.97 MillionStrongbridge Biopharma plc (NASDAQ:SBBP) Expected to Announce Quarterly Sales of $5.97 Million
www.americanbankingnews.com - April 5 at 2:36 AM
 Analysts Anticipate Strongbridge Biopharma plc (NASDAQ:SBBP) to Post -$0.20 Earnings Per Share Analysts Anticipate Strongbridge Biopharma plc (NASDAQ:SBBP) to Post -$0.20 Earnings Per Share
www.americanbankingnews.com - April 3 at 9:12 PM
Strongbridge Biopharma plc (NASDAQ:SBBP) Given Average Rating of "Buy" by BrokeragesStrongbridge Biopharma plc (NASDAQ:SBBP) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 3 at 1:40 AM
Strongbridge Biopharma plc (NASDAQ:SBBP) Short Interest Up 39.9% in MarchStrongbridge Biopharma plc (NASDAQ:SBBP) Short Interest Up 39.9% in March
www.americanbankingnews.com - March 28 at 2:10 AM
Strongbridge Biopharma plc (NASDAQ:SBBP) Short Interest Down 5.9% in FebruaryStrongbridge Biopharma plc (NASDAQ:SBBP) Short Interest Down 5.9% in February
www.americanbankingnews.com - March 15 at 7:45 AM
$5.97 Million in Sales Expected for Strongbridge Biopharma plc (NASDAQ:SBBP) This Quarter$5.97 Million in Sales Expected for Strongbridge Biopharma plc (NASDAQ:SBBP) This Quarter
www.americanbankingnews.com - March 13 at 4:30 AM
Edited Transcript of SBBP earnings conference call or presentation 25-Feb-20 1:30pm GMTEdited Transcript of SBBP earnings conference call or presentation 25-Feb-20 1:30pm GMT
finance.yahoo.com - March 5 at 9:50 AM
If You Had Bought Strongbridge Biopharma (NASDAQ:SBBP) Shares Five Years Ago You'd Have Made 139%If You Had Bought Strongbridge Biopharma (NASDAQ:SBBP) Shares Five Years Ago You'd Have Made 139%
finance.yahoo.com - February 27 at 1:35 PM
Strongbridge Biopharma plc to Present at the Cowen and Company 40th Annual Healthcare ConferenceStrongbridge Biopharma plc to Present at the Cowen and Company 40th Annual Healthcare Conference
finance.yahoo.com - February 27 at 8:34 AM
Strongbridge Biopharma EPS beats by $0.02, revenue in-lineStrongbridge Biopharma EPS beats by $0.02, revenue in-line
seekingalpha.com - February 25 at 1:40 PM
Strongbridge Biopharma (SBBP) Reports Q4 Loss, Tops Revenue EstimatesStrongbridge Biopharma (SBBP) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - February 25 at 1:40 PM
Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate UpdateStrongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update
www.benzinga.com - February 25 at 7:42 AM
Strongbridge Biopharma plc to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 25, 2020Strongbridge Biopharma plc to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 25, 2020
finance.yahoo.com - February 19 at 12:07 PM
Strongbridge Biopharma plc Announces New Employment Inducement AwardsStrongbridge Biopharma plc Announces New Employment Inducement Awards
finance.yahoo.com - January 30 at 6:57 PM
Strongbridge Biopharma: A Big Opportunity For Cushings Syndrome Patients And For InvestorsStrongbridge Biopharma: A Big Opportunity For Cushing's Syndrome Patients And For Investors
seekingalpha.com - January 30 at 8:55 AM
Strongbridge Bio sees Keveyis net sales for FY 2019 as high as $21.7MStrongbridge Bio sees Keveyis net sales for FY 2019 as high as $21.7M
seekingalpha.com - January 9 at 5:13 PM
Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2019 Financial Results and Provides Update on Corporate PrioritiesStrongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2019 Financial Results and Provides Update on Corporate Priorities
finance.yahoo.com - January 9 at 5:13 PM
Sifting Through The Story At Strongbridge BiopharmaSifting Through The Story At Strongbridge Biopharma
seekingalpha.com - December 10 at 9:35 AM
Bucks County biopharm firm makes more job cutsBucks County biopharm firm makes more job cuts
finance.yahoo.com - November 18 at 3:32 PM
Strongbridge Bio axes 15 more jobs to cut costsStrongbridge Bio axes 15 more jobs to cut costs
seekingalpha.com - November 18 at 10:29 AM
Strongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead IndependentStrongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead Independent
www.bloomberg.com - November 18 at 10:29 AM
Strongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead Independent DirectorStrongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead Independent Director
finance.yahoo.com - November 18 at 10:29 AM
Edited Transcript of SBBP earnings conference call or presentation 7-Nov-19 1:30pm GMTEdited Transcript of SBBP earnings conference call or presentation 7-Nov-19 1:30pm GMT
finance.yahoo.com - November 15 at 5:20 PM
Strongbridge Biopharma plc to Present at Two Upcoming Investor ConferencesStrongbridge Biopharma plc to Present at Two Upcoming Investor Conferences
finance.yahoo.com - November 12 at 8:06 AM
Strongbridge Biopharma (SBBP) Reports Q3 Loss, Tops Revenue EstimatesStrongbridge Biopharma (SBBP) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 7 at 2:39 PM
Strongbridge Biopharma plc (SBBP) Q3 2019 Results - Earnings Call TranscriptStrongbridge Biopharma plc (SBBP) Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 12:34 PM
Strongbridge Biopharma EPS beats by $0.06, beats on revenueStrongbridge Biopharma EPS beats by $0.06, beats on revenue
seekingalpha.com - November 7 at 8:32 AM
Strongbridge Biopharma plc Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateStrongbridge Biopharma plc Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 8:32 AM
Bucks County biopharma firm's CEO departsBucks County biopharma firm's CEO departs
finance.yahoo.com - November 6 at 8:40 AM
Bucks County biopharm firms CEO departsBucks County biopharm firm's CEO departs
www.bizjournals.com - November 5 at 6:30 PM
Bucks County biopharm firm's CEO departsBucks County biopharm firm's CEO departs
finance.yahoo.com - November 5 at 6:30 PM
Strongbridge Biopharma down 30% on CEO departureStrongbridge Biopharma down 30% on CEO departure
seekingalpha.com - November 5 at 1:29 PM
Strongbridge Biopharma plc Announces CEO Transition Plan and Provides Preliminary Third Quarter 2019 Financial Results and Corporate UpdatesStrongbridge Biopharma plc Announces CEO Transition Plan and Provides Preliminary Third Quarter 2019 Financial Results and Corporate Updates
finance.yahoo.com - November 5 at 8:29 AM
Strongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseStrongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - October 31 at 1:36 PM
Strongbridge Biopharma plc to Host Third Quarter 2019 Financial Results Conference Call on November 7, 2019Strongbridge Biopharma plc to Host Third Quarter 2019 Financial Results Conference Call on November 7, 2019
finance.yahoo.com - October 29 at 12:08 PM
Will Strongbridge Biopharma (SBBP) Report Negative Q3 Earnings? What You Should KnowWill Strongbridge Biopharma (SBBP) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - October 23 at 1:22 PM
Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Association of Neuromuscular & Electrodiagnostic Medicine Annual MeetingStrongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting
finance.yahoo.com - October 17 at 8:15 AM
Strongbridge Biopharma (SBBP) Presents At Cantor Healthcare Conference - SlideshowStrongbridge Biopharma (SBBP) Presents At Cantor Healthcare Conference - Slideshow
seekingalpha.com - October 4 at 5:09 PM
Strongbridge Biopharma plc to Present at the 2019 Cantor Global Healthcare ConferenceStrongbridge Biopharma plc to Present at the 2019 Cantor Global Healthcare Conference
www.benzinga.com - September 25 at 9:39 AM
Strongbridge Biopharma plc Announces RECORLEV™ (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & EndocrinologyStrongbridge Biopharma plc Announces RECORLEV™ (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & Endocrinology
finance.yahoo.com - September 19 at 10:55 PM
Strongbridge Biopharma plc to Present at the H.C. Wainwright 21st Annual Global Investment Conference and the Janney Montgomery Scott Healthcare Conference 2019Strongbridge Biopharma plc to Present at the H.C. Wainwright 21st Annual Global Investment Conference and the Janney Montgomery Scott Healthcare Conference 2019
finance.yahoo.com - September 3 at 10:45 AM
Executives on the move at Strongbridge BiopharmaExecutives on the move at Strongbridge Biopharma
seekingalpha.com - August 13 at 5:44 PM
Strongbridge Biopharma Announces Key Leadership Appointments to Support Next Stage of GrowthStrongbridge Biopharma Announces Key Leadership Appointments to Support Next Stage of Growth
finance.yahoo.com - August 13 at 10:41 AM
Edited Transcript of SBBP earnings conference call or presentation 31-Jul-19 12:30pm GMTEdited Transcript of SBBP earnings conference call or presentation 31-Jul-19 12:30pm GMT
finance.yahoo.com - August 2 at 10:04 AM
Strongbridge Biopharmas (SBBP) CEO Matthew Pauls on Q2 2019 Results - Earnings Call TranscriptStrongbridge Biopharma's (SBBP) CEO Matthew Pauls on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - July 31 at 5:28 PM
Strongbridge Biopharma EPS beats by $0.03, beats on revenueStrongbridge Biopharma EPS beats by $0.03, beats on revenue
seekingalpha.com - July 31 at 10:05 AM
Strongbridge Biopharma plc Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateStrongbridge Biopharma plc Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - July 31 at 10:05 AM
Strongbridge Biopharma (SBBP) Reports Q2 Loss, Tops Revenue EstimatesStrongbridge Biopharma (SBBP) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - July 31 at 10:05 AM
Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31
www.nasdaq.com - July 24 at 10:13 AM
Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31, 2019Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31, 2019
finance.yahoo.com - July 24 at 10:13 AM
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel